The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2014

Filed:

Jul. 25, 2011
Applicants:

Jay Lichter, Rancho Santa Fe, CA (US);

Benedikt Vollrath, San Diego, CA (US);

Andrew M. Trammel, Olathe, KS (US);

Sergio G. Durón, San Diego, CA (US);

Fabrice Piu, San Diego, CA (US);

Luis A. Dellamary, San Marcos, CA (US);

Qiang YE, San Diego, CA (US);

Carl Lebel, Malibu, CA (US);

Michael Christopher Scaife, Los Altos, CA (US);

Jeffrey P. Harris, La Jolla, CA (US);

Inventors:

Jay Lichter, Rancho Santa Fe, CA (US);

Benedikt Vollrath, San Diego, CA (US);

Andrew M. Trammel, Olathe, KS (US);

Sergio G. Durón, San Diego, CA (US);

Fabrice Piu, San Diego, CA (US);

Luis A. Dellamary, San Marcos, CA (US);

Qiang Ye, San Diego, CA (US);

Carl Lebel, Malibu, CA (US);

Michael Christopher Scaife, Los Altos, CA (US);

Jeffrey P. Harris, La Jolla, CA (US);

Assignees:

Otonomy, Inc., San Diego, CA (US);

The Regents of the University of California, Oakland, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 45/00 (2006.01); A61K 31/56 (2006.01); A61K 47/30 (2006.01); C07J 1/00 (2006.01); A61K 9/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed herein are compositions and methods for the treatment of otic disorders with steroid, NSAID, and/or adenosine triphosphatase ('ATPase') modulator agents. In these methods, the steroidal, NSAID, and/or ATPase compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).


Find Patent Forward Citations

Loading…